Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

EVP, Global CAO and GC of Walgreens Boots Alliance Inc (30-Year Financial, Insider Trades) Marco Patrick Anthony Pagni (insider trades) sold 215,323 shares of WBA on 08/14/2019 at an average price of $50.48 a share.

Walgreens Boots Alliance Inc (WBA) EVP, Global CAO and GC Marco Patrick Anthony Pagni Sold $10.9 million of Shares

Walgreens Boots Alliance's share price has moved south over the past few months, and it's a company I return to from time to time to add more shares.

Walgreens Still Undervalued - I'm Buying More

Buy Walgreens at its quarterly pivot at $52.62 and reduce holding on strength to its semiannual risky level at $57.74.

Walgreens Stock Now ‘Too Cheap to Ignore’

The Walgreens stores closing list continues to grow as it adds 200 locations in the U.S after reviewing results from its earnings report.
The post 200 Walgreens Stores Closing in U.S.

200 Walgreens Stores Closing in U.S.

Walgreens plans to close about 200 stores in the U.S., the pharmacy chain disclosed in a Securities and Exchange Commission filing released Tuesday.

Walgreens plans to close about 200 U.S. stores

Walgreens Boots Alliance Inc  said on Tuesday it plans to close about 200 U.S. stores and expects to record related pre-tax charges of between $1.9 billion and $2.4 billion.

Walgreens to close about 200 stores in United States

Walgreens said the closures will affect about 3% of its U.S. footprint.

Walgreens to close 200 stores in US

Amazon

CVS Health

Amazon's PillPack unit is battling CVS and Walgreens over requests to transfer patients to its mail-delivery pharmacy.

Amazon's PillPack is battling with CVS and Walgreens over getting patient prescriptions

Kroger

J. M. Smucker

Each of these companies has lifted its payout for at least 13 years in a row, and they each look set to extend the streak.

3 Stocks That Just Raised Their Dividends

Walgreens (WBA) reported earnings 30 days ago. What's next for the stock?

Why Is Walgreens (WBA) Up 1% Since Last Earnings Report?

Only two of the Dow 30 components are down this year. Pfizer (NYSE: PFE) is barely off, by 1.28% to $43.09.

This Stock Is Killing The Dow

Costco Wholesale (NASDAQ:COST) released its latest set of monthly sales figures late in the afternoon today.

Walgreens raises dividend by 4%

Walgreens Boots Alliance Inc. WBA, +0.13% announced Wednesday that it would be increasing its quarterly dividend by 4% to 45.75 cents per share.

Walgreens will increase quarterly dividend by 4%

A woeful 12 months have sent Walgreens shares below the $50 range due to decreasing drug prices, the decline of brick-and-mortar retail, and growing online competition.

Walgreens Finally Entering A Buying Point?

Walgreens' shares perked up last month following an upbeat third-quarter earnings report.

Why Walgreens Boots Alliance Stock Reversed Course in June

Gap Inc

Albemarle

National Beverage

Walgreens and Gap Are on My Casualty List

AbbVie

Allergan

McKesson

My investment management firm has a large position in the health care sector, and with AbbVie’s bid for Allergan earlier this week, it’s timely to review why we bought into this sector.

Here's Why Drug-Distribution and Pharmacy Stocks Are Bargains Now

Walgreens (NYSE:WBA) announced its Q3 2019 (ended May 2019) results on June 27, 2019, followed by a conference call with analysts. The company just beat consensus for revenue which was recorded at $34.5 billion, up by 0.7% y-o-y.

Walgreens Operating Margins Fall For Q3 2019, Full Year Guidance Maintained

Walgreens stock has badly underperformed the broader markets over the last three years. Can this top drugstore chain mount a comeback?

Is Walgreens Boots Alliance a Buy?

Walgreens Boots' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also benefiting from a strong retail prescription market.

Walgreens Gains on Strategic Deals, Margin Pressure Remains

These beaten up stocks have big rebound potential.

4 Beaten-Up Stocks With Strong Rebound Potential

Pfizer

UnitedHealth Group

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Health-related stocks were among the worst-performing Dow Jones stocks during the first half of 2019, led by Walgreens Boots Alliance.

These Are The 5 Worst Dow Jones Stocks In The First Half Of 2019

Walgreens Boots Alliance Inc (NASDAQ: WBA) on Thursday reported fiscal third-quarter results, which prompted Wells Fargo to reaffirm a bullish stance.

A Walgreens Analyst's Takeaways From Q3 Earnings

KB Home

Walgreens reported improving sales, and results from KB Home were good news for homebuilders today.

What Happened in the Stock Market Today (June 27)

A lackluster quarter wasn't as bad as expected.

News for Walgreens Stock (WBA)